Hong Kong Stock Movement | CStone Pharmaceuticals-B (02616.HK) Rises Nearly 7% in Early Trading as CS2009 Achieves Major Clinical Validation Milestone and Is Announced at ESMO 2026

Zhitong Finance APP has learned that CStone Pharmaceuticals-B (02616.HK) rose nearly 7% in early trading. As of press time, it was up 3.39% at HK$5.035, with a turnover of HK$19.2195 million.